Announced today that Merrimack Pharmaceuticals.

For further information please visit About RNAscope ACD's RNAscope represents a significant technological advance in in situ RNA recognition. This patented, breakthrough platform is the first to enable robust single RNA molecule recognition in routine formalin-fixed, paraffin-embedded medical specimens. RNAscope provides rich morphological and molecular info in one assay to increase the clinical utility of RNA biomarkers. This is especially true in cancer diagnostics because of the significant intra-tumor heterogeneity and the complex involvement of the tumor microenvironment in tumor growth and therapeutic response.2, 2015 – – Seniors who break a hip have the best treatment in skilled nursing facilities with the most knowledge managing such fractures, a fresh study suggests. Twenty-five cases a complete year was the magic quantity, according to lead author Pedro Gozalo, associate professor of health services, plan and practice at the educational school of General public Health at Dark brown University in Providence, R.I., and colleagues. Even adjusting for a long list of patient risk factors and for important facility characteristics, services that had looked after a lot more than two dozen hip fracture patients in the last 12 weeks were a lot more than twice seeing that more likely to successfully discharge patients regularly compared to facilities that had 3 or less hip fracture admissions, Gozalo said in a university news launch.